Why are Pharma Companies Ready to Invest in Real World Evidence?

Why are Pharma Companies Ready to Invest in Real World Evidence?

Randomized Clinical Trials (RCTs) gather clinical data from a small and limited set of samples. It is increasingly being challenged by the payers and healthcare providers as a method to measure the safety and efficacy of drugs. Since the data gathered from RCTs are obtained in a highly controlled environment over a short period of […]

READ MORE >>